A viro-immunological model to characterize the antiviral effect of molnupiravir in SARS-CoV-2-infected outpatients: implication for treatment duration.
Nguyen BT. et al, (2025), J Infect Dis
The impact of the COVID-19 pandemic on antimicrobial usage: An international patient-level cohort study
Farzana R. et al, (2025), JAC-Antimicrobial Resistance, 7
Benefits of aldosterone receptor antagonism in chronic kidney disease: the BARACK-D RCT.
Hobbs FDR. et al, (2025), Health Technol Assess, 29, 1 - 130
Self-monitoring of blood pressure following a stroke or transient ischaemic attack (TASMIN5S): a randomised controlled trial
McManus RJ. et al, (2024), BMC Cardiovascular Disorders, 24
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial
Farmer AJ. et al, (2024), Pilot and Feasibility Studies, 10
User engagement in clinical trials of digital mental health interventions: a systematic review
Elkes J. et al, (2024), BMC Medical Research Methodology, 24
Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage
Toader AM. et al, (2024), Trials, 25
Utilising primary care electronic health records to deliver the ALABAMA randomised controlled trial of penicillin allergy assessment
Ahmed S. et al, (2024), Trials, 25
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hobbs FR. et al, (2024), Journal of Infection, 89
Effect of antihypertensive deprescribing on hospitalisation and mortality: long-term follow-up of the OPTiMISE randomised controlled trial
Sheppard JP. et al, (2024), The Lancet Healthy Longevity, 5, e563 - e573
Nurse-delivered sleep restriction therapy to improve insomnia disorder in primary care: the HABIT RCT
Kyle SD. et al, (2024), Health Technology Assessment, 1 - 107
FOUND Trial: randomised controlled trial study protocol for case finding of obstructive sleep apnoea in primary care using a novel device
Miller MA. et al, (2024), BMJ Open, 14
Effect of antihypertensive deprescribing on serious adverse events, mortality, and cardiovascular disease: Long-term follow-up of the OPTiMISE randomised controlled trial
SHEPPARD J. et al, (2024), The Lancet Healthy Longevity
EFFECT OF ANTIHYPERTENSIVE DEPRESCRIBING ON SERIOUS ADVERSE EVENTS, MORTALITY, AND CARDIOVASCULAR DISEASE: LONG-TERM FOLLOW-UP OF THE OPTIMISE RANDOMISED CONTROLLED TRIAL
Sheppard J. et al, (2024), Journal of Hypertension, 42, e109 - e110
Paediatric meningitis in the conjugate vaccine era and a novel clinical decision model to predict bacterial aetiology
Martin NG. et al, (2024), Journal of Infection, 88
Intravenous immunoglobulin treatment for encephalitis in children aged 6 months to 16 years: the IgNiTE RCT
Iro MA. et al, (2024), Efficacy and Mechanism Evaluation, 1 - 53
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hayward G. et al, (2024), Journal of Infection, 88
Digitally augmented, parent-led CBT versus treatment as usual for child anxiety problems in child mental health services in England and Northern Ireland: a pragmatic, non-inferiority, clinical effectiveness and cost-effectiveness randomised controlled trial
Creswell C. et al, (2024), The Lancet Psychiatry, 11, 193 - 209
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Standing JF. et al, (2024), Nature communications, 15